The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics.
about
Algae-based oral recombinant vaccinesA Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protectionAlgae-produced Pfs25 elicits antibodies that inhibit malaria transmissionPlants as Factories for Human Pharmaceuticals: Applications and ChallengesEmerging targets in lipid-based therapyThe challenge of ecophysiological biodiversity for biotechnological applications of marine microalgaeBuilding a multipurpose insertional mutant library for forward and reverse genetics in Chlamydomonas.Production of unique immunotoxin cancer therapeutics in algal chloroplastsProtein N-glycosylation in eukaryotic microalgae and its impact on the production of nuclear expressed biopharmaceuticals.Robust expression and secretion of Xylanase1 in Chlamydomonas reinhardtii by fusion to a selection gene and processing with the FMDV 2A peptide.Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines.Recent advances on host plants and expression cassettes' structure and function in plant molecular pharming.Future directions for the development of Chlamydomonas-based vaccines.Dunaliella salina as a novel host for the production of recombinant proteins.Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses.The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins.Chlamydomonas as a model for biofuels and bio-products production.Genes involved in the endoplasmic reticulum N-glycosylation pathway of the red microalga Porphyridium sp.: a bioinformatic study.Outlook in the application of Chlamydomonas reinhardtii chloroplast as a platform for recombinant protein production.Microalgal bioengineering for sustainable energy development: Recent transgenesis and metabolic engineering strategies.Role of riboswitches in gene regulation and their potential for algal biotechnology.New lipid-producing, cold-tolerant yellow-green alga isolated from the Rocky Mountains of Colorado.Genetic manipulation, a feasible tool to enhance unique characteristic of Chlorella vulgaris as a feedstock for biodiesel production.A novel bicistronic expression system composed of the intraflagellar transport protein gene ift25 and FMDV 2A sequence directs robust nuclear gene expression in Chlamydomonas reinhardtii.An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency.Improving recombinant protein production in the Chlamydomonas reinhardtii chloroplast using vivid Verde Fluorescent Protein as a reporterIce recrystallization inhibition mediated by a nuclear-expressed and -secreted recombinant ice-binding protein in the microalga Chlamydomonas reinhardtii.A Toxicological Evaluation of Chlamydomonas reinhardtii, a Green Algae.Identification of Chlamydomonas reinhardtii endogenous genic flanking sequences for improved transgene expression.Introducing Dunaliella LIP promoter containing light-inducible motifs improves transgenic expression in Chlamydomonas reinhardtii.
P2860
Q21131110-990EF2D3-DA2A-43DF-8BDA-C299B0089A23Q21133563-B0D6A8BD-E0AD-4007-9E41-0B7CC431361EQ21134576-6DA2BE41-48F1-430E-9F32-6BB93660D236Q26775069-C470865E-DAF8-4936-A371-77480C6743D6Q28655456-8D36D7AD-04B8-49DF-9954-04A599F5583DQ28660622-3FCB0475-857F-4151-BFC4-6D14272D6E69Q33681757-9C0F7C99-5706-45DD-B6B8-51E8C3B21A4DQ34034756-10FBB527-49F6-4F21-A73F-731955665583Q34054932-05371287-D32E-499D-8309-3863AF215A22Q34399087-9F83DD1C-0085-42E2-969F-21349970D866Q36970645-B8656620-5F6D-4B8C-A903-96E73F994A89Q38130165-FF635362-1721-45DA-B75D-7CA4B91B5058Q38140036-950C2D67-5475-4030-B473-636A7FF5FFD3Q38197116-FC505919-6185-4161-97F1-65B417900321Q38198558-0295CD8B-0C66-4C38-94D2-23AADABCC0F6Q38239254-9AFF21E9-997E-4AC6-A08F-4C86803D133DQ38340182-EF307D52-58B7-4D4E-9BC3-DE04FFC215A9Q38344906-DB698729-B216-45FD-AA15-B5455FB50F7BQ38371816-B7C85B55-DAFC-4A67-8EF7-1817606B7D1CQ38722735-26ABD63B-BA71-40B9-BA0C-9C7BCAB8BF7AQ38796147-BADCA261-144A-4CB1-BF76-91F82EE42514Q39123031-813CFFF3-E7FE-44D3-9D02-A9C5BB19E82BQ39423022-5CC0A507-91D8-441D-8A09-D50F84414E3AQ40318156-36D7E82B-4787-47CE-9FD4-85A80B080928Q41694249-A44E945C-21B4-45BA-8084-F0371EB843AFQ42025528-2A9FAF55-30CF-48C0-8D36-69E60D401A98Q45405038-4A800A1D-81BA-42B5-A06A-F9EDB3B8A35BQ47557561-8E639AB2-0735-446D-8628-F76EDCF24C53Q47694345-A469D899-ED05-4DDB-86AC-C89A0584CF80Q50235134-8350D207-52C7-4866-A7CC-5DBFF497E77A
P2860
The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The microalga Chlamydomonas re ...... of human protein therapeutics.
@ast
The microalga Chlamydomonas re ...... of human protein therapeutics.
@en
type
label
The microalga Chlamydomonas re ...... of human protein therapeutics.
@ast
The microalga Chlamydomonas re ...... of human protein therapeutics.
@en
prefLabel
The microalga Chlamydomonas re ...... of human protein therapeutics.
@ast
The microalga Chlamydomonas re ...... of human protein therapeutics.
@en
P2860
P356
P1433
P1476
The microalga Chlamydomonas re ...... of human protein therapeutics.
@en
P2093
Beth A Rasala
Stephen P Mayfield
P2860
P356
10.4161/BBUG.2.1.13423
P577
2011-01-01T00:00:00Z